Purinergic P2Y Receptor Antagonists

DBCAT000532Pharmacologic class

Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes. A DrugBank category of 5 drugs. 5 of them are approved.

Also known as: Adenosine Diphosphate Receptor Antagonists · ADP Receptor Antagonists · ADP Receptor Blockers · Antagonists, ADP Receptor · Antagonists, P2Y Purinoceptor
Drugs: Cangrelor
Clopidogrel
Prasugrel
Ticagrelor
Ticlopidine

What you can answer from here — as of August 24, 2016

5DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

2,336Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Purinergic P2Y Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account